Company Overview and News

5
Bond traders eye Fed speakers for sign of doubt

18h thestar.com.my
NEW YORK: Bond traders will look to key Federal Reserve speakers this week for any signs that officials are wavering from their plans to keep hiking rates gradually after US stocks suffered their worst weekly sell-off since March.
C CRARF CGBBW ACA CRARY

 
America First is hurting China's business

2018-10-05 channelnewsasia
The U.S. economy has pulled ahead this year, extending a lengthy expansion with help from President Donald Trump's "America First" agenda and massive tax cuts, but upcoming data could illuminate the impact of his policies on global peers.
ACA CRARY CRARF

 
America First is hurting China's business

2018-10-05 reuters
LONDON (Reuters) - The U.S. economy has pulled ahead this year, extending a lengthy expansion with help from President Donald Trump’s “America First” agenda and massive tax cuts, but upcoming data could illuminate the impact of his policies on global peers.
ACA CRARY CRARF

 
Dollar perched at six-week highs on US yield surge

2018-10-04 malaymail
LONDON, Oct 4 — The dollar held at a six-week high today as an overnight jump in US Treasury yields on the back of strong data prompted investors to add long bets in the greenback against higher-yielding and emerging market currencies.
ACA CRARY CRARF

2
Italy weighs on global stocks, but Dow bucks trend to mark record high close

2018-10-02 theedgemarkets
New York (Oct 3): Stock indexes around the globe weakened on Tuesday, European assets sold off and Italy's bond yields hit multiyear highs after an Italian lawmaker made anti-euro comments, though Wall Street's blue-chip index bucked the trend and set a new record.
ACA CRARY CRARF MSCI

2
Global stocks dip amid Italy angst, but tech lifts Dow

2018-10-02 financialexpress
Stocks were shaky around the globe and European assets sold off on Tuesday as anti-euro comments by an Italian lawmaker sent Italy’s bond yields to multi-year highs and optimism over an agreement to revamp a North American trade deal receded. The MSCI world equity index dipped 0.2 percent, paring Monday’s gains that followed the new U.S.-Mexico-Canada trade deal. The pan-European FTSEurofirst 300 index lost 0.
ACA CRARY CRARF MSCI

2
Italy weighs on global stocks, but Dow bucks trend to mark record high close

2018-10-02 reuters
New York (Reuters) - Stock indexes around the globe weakened on Tuesday, European assets sold off and Italy’s bond yields hit multi-year highs after an Italian lawmaker made anti-euro comments, though Wall Street’s blue-chip index bucked the trend and set a new record.
ACA CRARY CRARF MSCI

2
Global stocks dip amid Italy angst, but tech lifts Dow

2018-10-02 reuters
New York (Reuters) - Stocks were shaky around the globe and European assets sold off on Tuesday as anti-euro comments by an Italian lawmaker sent Italy’s bond yields to multi-year highs and optimism over an agreement to revamp a North American trade deal receded.
ACA CRARY CRARF MSCI

 
Euro weakens to six-week low as Italian concerns weigh

2018-10-02 reuters
NEW YORK (Reuters) - The euro fell to a six-week low on Tuesday after a senior lawmaker in one of Italy’s ruling parties said most of the country’s problems would be resolved if it readopted a national currency.
ACA CRARY CRARF

2
Global stocks dip as Italy angst takes hold, NAFTA lift dwindles

2018-10-02 reuters
New York (Reuters) - Stocks weakened around the globe and European assets sold off on Tuesday as anti-euro comments by an Italian lawmaker sent Italy’s bond yields to multi-year highs and optimism over an agreement to revamp a North American trade deal receded.
ACA CRARY CRARF MSCI

 
Euro weakens to six-week low; Italian concerns weigh

2018-10-02 reuters
NEW YORK (Reuters) - The euro fell to a six-week low on Tuesday after a senior lawmaker in one of Italy’s ruling parties said most of the country’s problems would be resolved if it readopted a national currency.
ACA CRARY CRARF

 
Euro slides after Italian lawmaker talks up national currency

2018-10-02 reuters
LONDON (Reuters) - The euro fell to a six-week low on Tuesday after a senior official from Italy’s ruling party said most of the country’s problems would be resolved if it scrapped the euro for a national currency, triggering a broad market sell-off.
ACA CRARY CRARF

 
Euro slides after Italian lawmaker mentions return to own currency

2018-10-02 reuters
LONDON (Reuters) - The euro fell towards a five-week low on Tuesday after a senior official from Italy’s ruling party said most of the country’s problems would be resolved if it scrapped the euro for its own currency.
ACA CRARY CRARF

14
Rescued NAFTA deal lifts stocks, Canadian dollar

2018-10-01 reuters
NEW YORK (Reuters) - A last-minute agreement between the United States and Canada to rescue a trilateral NAFTA accord with Mexico drove up global stock markets and the Canadian dollar on Monday.
ACA GM CRARY CRARF

 
US dollar cements gains on growing rate gap bets

2018-10-01 malaymail
LONDON, Oct 1 — The dollar consolidated recent gains and held below a near one-month high today as higher US Treasury yields boosted appeal for the greenback while the euro struggled to stay above 1.16 levels on the Italian budget concerns.
SCGLF ACA SCGLY GLE CRARY CRARF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to EPA:ACA / CREDIT AGRICOLE on message board site Silicon Investor.

ACADIA Pharmaceuticals Inc (ACAD) ACADIA Pharmaceuticals Inc (ACAD) ACADIA Pharmaceuticals Inc (ACAD) Acacia Communications Acacia Communications Acacia Communications
Acacia Research-ACTG Acacia Research-ACTG Acacia Research-ACTG WYNN MACAU WYNN MACAU WYNN MACAU
IVC: Invacare Corporation IVC: Invacare Corporation IVC: Invacare Corporation The Gracious Academy The Gracious Academy The Gracious Academy
Clinton Unable to Save Sink from Obamacare in FL Election Clinton Unable to Save Sink from Obamacare in FL Election Clinton Unable to Save Sink from Obamacare in FL Election *** ACAD REPORT *** *** ACAD REPORT *** *** ACAD REPORT ***
International Datacasting - Takeover Target? International Datacasting - Takeover Target? International Datacasting - Takeover Target? Louis Navellier, HTCH, SOL, ACAS 6/1/98 Louis Navellier, HTCH, SOL, ACAS 6/1/98 Louis Navellier, HTCH, SOL, ACAS 6/1/98